Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Hypertension. 2017 Jun 19;70(2):420–425. doi: 10.1161/HYPERTENSIONAHA.117.09354

Figure 1. Baseline leukocyte telomere length (left) and leukocyte telomere attrition during the follow-up period (right) versus the presence of carotid atherosclerotic plaques during the baseline/follow-up visits.

Figure 1

Adjusted baseline LTL (kb) versus the presence of CAP at baseline and follow-up (left); Adjusted LTL attrition (bp/year) versus the presence of CAP at baseline and follow-up (right).

Values are mean ± SEM. BL, baseline; CAP, carotid atherosclerotic plaque; LTL, leukocyte telomere length, kb, kilo base pairs; bp, base pair; no/no: absence of CAP in both baseline and follow-up examinations; no/yes: presence of CAP only at the follow-up examination; yes/yes: presence of CAP in both baseline and follow-up examinations.

BL LTL is adjusted to age and sex; LTL attrition is adjusted to age, sex and baseline value of LTL.